The outstanding growth of the pharmaceutical biotechnology industry means new challenges for classical pharmaceutical companies.
Our Know-how - your profit
A large number of pharmaceutical companies are competing for only a few innovative technologies and products in this sector. Especially big companies often lack the capability, flexibility, and required speed of operation to develop the necessary technological know-how for the formulation of biopharmaceuticals within the company.
celares GmbH is an established drug delivery company which provides customized solutions for these problems. We develop and produce new, biocompatible, polyethylene glycol based drug delivery systems. The goal of celares GmbH is the sustained enhancement of therapeutic possibilities and the improvement of pharmacological properties of already approved or new biopharmaceuticals. The application of PEGylation or chemical modification by celares GmbH opens up new and expanded possibilities for the delivery of drugs.
The offer of celares GmbH is addressed especially to drug developers and drug manufacturers. Through flexibility, know-how, and high quality we will solve the customer's problems related to the application of biopharmaceuticals. celares GmbH combines many years of chemical and biotechnological experience within the company and offers customers the possibility to acquire forward-looking technology at a reasonable cost. Within the framework of contract developments we will optimize polyethylene glycol or polymer based formulations especially for your drug component. celares GmbH is an independent company and guarantees the complete confidentiality and freedom to operate a pharmaceutical company depends on.
The focus of our work is the customer's profit through our know-how!